Catalyst Wire Dossier Catalyst Wire Dossier

Latanoprost 0.005%/Timolol 0.5% fixed-dose combination

latanoprost/timolol · Pfizer
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Latanoprost 0.005%/Timolol 0.5% fixed-dose combination, covering 2013-03-28 to 2013-03-28. Get the full timeline:

Most recent: Clinical Trial Update: Travoprost 0.004%/Timolol 0.5% Versus Latanoprost 0.005%/Timolol in Chinese Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 3]

See pricing